Verve Therapeutics, Inc. (VERV)
| Market Cap | 2.28B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -53.36M |
| Shares Out | 45.75M |
| EPS (ttm) | -1.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 27 |
| Last Price | $49.92 |
| Previous Close | $52.52 |
| Change ($) | -2.60 |
| Change (%) | -4.95% |
| Day's Open | 52.44 |
| Day's Range | 49.05 - 53.49 |
| Day's Volume | 291,301 |
| 52-Week Range | 29.50 - 73.80 |
The dictionary describes the word “verve” as having energy, or vitality. It seems appropriate, then, that shares of biotech startup Verve Therapeutics, Inc. ( VERV , Financial) are up nearly $170% to $5...
Find out why these stocks are climbing higher.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verve Therapeutics, a biotech company pioneering a new approach to the care of cardiovascular disease with single-course gene editing medicines, today announced the pr...
Verve Therapeutics, Inc. has filed to go public with an IPO on the NASDAQ.
A team of researchers from Verve Therapeutics and the Perelman School of Medicine at the University of Pennsylvania has developed a CRISPR gene-editing technique that lowered the levels of cholesterol i...
VerveTx Announces Nature Publication Highlighting its Use of Base Editing to Potently and Durably Lower Blood PCSK9 and LDL-C in Non-Human Primates
About VERV
Verve Therapeutics is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, or CVD, transforming treatment from chronic management to single-course gene editing medicines. The current paradigm of chronic care is fragile – requiring rigorous patient adherence, extensive healthcare infrastructure and regular healthcare access – and leaves many patients without adequate care. Our goal is to disrupt the chronic care model for CVD by providing a new therapeutic approach with single-course in vivo gene editi... [Read more...]
| Industry Biotechnology | IPO Date Jun 17, 2021 |
| CEO Sekar Kathiresan, M.D. | Employees 63 |
| Stock Exchange NASDAQ | Ticker Symbol VERV |